In a long series of cyclosporins obtained by in vitro and in vivo biosynthesis, [Melle 4]cyclosporin represents the first example that is devoid of immunosuppressive efficacy while retaining strong binding to cyclophilin. It exerts potent in vitro anti-HIV-1 activity.
Cyclosporin A (CyA; Fig. 1a ) is a cyclic undecapeptide which is produced as the main component of at least 25 so-called 'natural cyclosporins' (Traber et el., 1987) by the fungus Tolypocladium niveum (also designated Beauveda nivea) . CyA exhibits many biological activities, including anti-inflammatory, antifungal, antiparasitic and immunosuppressive activities (Borel, 1986) . It is commonly used in transplantation surgery (Kahan, 1984) and in the treatment of autoimmune diseases (Schindler, 1985) .
The cellular CyA-binding protein cyclophilin (Handschumacher et sl., 1984) has recently been shown to bind to the human immunodeficiency virus type-1 (HIV-1) protein Gag. This binding can be inhibited by CyA (Luban et al., 1993) . Although CyA has been described as a potent agent in the treatment of HIV (Andrieu et et., 1988; Karpas et al., 1992) , its immunosuppressive activity prevents its use for this indication.
The enzyme responsible for the biosynthesis of cyclosporins has been determined to be a single polypeptide (Lawen and Zocher, 1990 ) with a molecular mass of about 1.4 MDa (Schmidt et st., 1992) . This enzyme has been used for the in Vitro synthesis of dozens of new cyclosporin analogues (Lawen et al., 1989; Lawen and Traber, 1993) , greatly increasing the number of cyclosporins known from chemical synthesis and precursor-directed fermentation.
Prompted by the high immunosuppressive activity of [D-Ser 8]CyA, a derivative ·of cyclosporin A obtained by \ From fermentations of Tolypocladium niveurn supplemented with D-threonine, a novel natural cyclosporin, [Melle 4]cyclosporin, was isolated. Its structural elucidation is based On amino acid analysis and spectroscopic data; the amino acid sequence was deduced from two-dimensional NMR investigations applied to the iso-derivative of [Melle 4]cyclosporin which, in contrast to the natural product, is present as one homogenous conformation in solution. We show that one of the four N-methyl-L-Ieucine units of cyclosporin A, namely that in position 4, is replaced by N-methyl-L-isoleucine. The putative mechanism by which D-threonine induces in vivo biosynthesis of [Melle 4]cyclosporin is discussed. In vitro biosynthesis of [Melle 4]cyclosporin was achieved using the Abbreviations: Abu, 2-aminobutyric acid; Bmt, (4R)-4-[(EJ-2-butenyl]-4methyl-L-threonine; GC, gas chromatography; COLOC, correlation via long-range coupling; COSY, two-dimensional correlation spectroscopy; Cy, cyclosporin; FAB, fast atom bombardment; HPTLC, high performance thin layer chromatography; Me, N-methyl; ROESY, two-dimensional rotational nuclear Overhauser enhancement spectroscopy; Sar, sarcosine; aThr, allo-threonine; TLC, thin layer chromatography. MeLeu (CyA);
precursor-directed biosynthesis (Traber et el., 1989) , we intended to prepare the [D-Thr 8]CyA analogue by the same method. However, the feeding of D-threonine to the fermentation medium did not lead to the desired compound; also, in the in vitro system D-threonine was not incorporated in position 8 by cyclosporin synthetase (Lawen and Traber, 1993) . Surprisingly, from fermentations supplemented with D-threonine, we were able to isolate a novel member of the cyclosporin group, [Melle 4]cyclosporin (abbreviated as [Melle 4]Cy) (1) ( Fig. 1b ), also designated SDZ NIM 811, which turned out to be a very potent anti-HIV-1 agent in vitro (Rosenwirth et ei., in press) . In this communication we report on its preparation, structural elucidation and direct enzymatic biosynthesis, as well as its anti-HIV-1 properties.
The physico-chemical properties of 1 are reported in Table1.
Structural elucidation
The elemental analysis and FAB mass spectrum showing a molecular ion peak at m/z 1202 (M+Ht showed that 1 and cyclosporin A were isomeric (C62H111N110d. The first indication of the presence of the amino acid MeBmt, which is characteristic of natural cyclosporins (von Wartburg and Traber, 1988) , came from the fragment peak in the mass spectrum (M+-112) corresponding to the elimination of C 7H 120 in the Bmt side-chain, and from the IR absorption at 970 crn"' (CH=CH trans). N-Methylation of 
Results

Isolation and characterization of [Melle 4Jcyciosporin (1)
From a 50-1 fermentation of Tolypocladium niveum, with the addition of D-threonine to the culture medium, a complex mixture of cyclosporins was obtained, cyclosporin A representing the main component. Besides cyclosporins Band C and some further cyclosporins produced as minor components (Traber et al., 1987) / all peptide bonds in 1 led to a derivative very similar, but not identical, to the N-permethylated product of cyclosporin A (Traber et ei., 1982) . This result suggested a close structural relationship between 1 and CyA. Hydrolytic cleavage of 1 and analysis of amino acids by gas chromatography using a chiral column revealed the presence of 1 L-Ala, 1 D-Ala, 1 L-Abu, 1 L-Val and 1 Sar; and furthermore, N-methylvaline, N-methylleucine and MeBmt-artifact (RQegger et el., 1976) , constituents also found in CyA, were detected. Isolation of the amino acids on a preparative scale confirmed the chiralities determined by gas chromatography (GC) analysis, and proved that MeVal and MeLeu belong to the L series. In addition, one unit of N-methyl-L-isoleucine was isolated from the hydrolysis mixture.
Information on the sequence of amino acids in 1, especially information as to which of the four MeLeu units in CyA is replaced by Melle, could not be obtained from NMR studies of 1 in CDCl 3 due to the presence of a heterogenous mixture of conformers for which interpretation of resonances was not possible. The recording of the spectrum in d 6-DMSO at an elevated temperature (180 DC) gave an improved resolution of signals, but in the important region of the a-protons the signals were still not sufficiently separated for unambiguous assignment. Previous observations have shown that isocyclosporins (as hydrochlorides) often appear in one homogenous confor-mation in CDC6 solution, e.g. isocyclosporin A and isocy-c1osporin H (H.R. Loosli and R. Traber, SANDOZ Pharma Ltd, unpublished results). Therefore, following the procedure for isocyclosporin A (RQegger et el., 1976), we prepared the iso-derivative of 1 by acid-catalysed N,D-acyl rearrangement between MeVal-11 and MeBmt-1. By comparison of the NMR assignments in iso-1 (as hydrochloride) ( Fig. 2) Fig..3) , the replacement of MeLeu with Melle at position 4 in 1 was concluded to have taken place, the remaining amino acid sequence being unchanged. Thus the chemical structure of 1 was deduced as [Melle 4jcyclosporin (Fig. 1b) .
In vitro biosynthesis of [Melle 4Jcyclosporin
MeLeu is a building block at four positions of the cyclosporin A ring, namely positions 4, 6, 9 and 10 ( Fig. 1a ). In our in vitro biosynthesis assay, it is therefore not possible to direct the exchange of one of these four methylleucines specifically, as has been extensively discussed earlier (Lawen and Traber, 1993) . lie is not accepted by the enzyme as a replacement for all these
four leucines (Lawen and Traber, 1993 
Biological activity
Although the replacement of the N-methyl-L-Ieucine unit at position 4 of CyA by N-methyl-L-isoleucine in [Melle 4]Cy may be considered as a minor structural modification, it has a great impact on biological activity.
[Melle 4]Cy still exhibits the inhibitory effect on filamentous fungi, e.g. Neurospora crassa, which is characteristic 0t most natural cyclosporins (Dreyfuss et al., 1976) , but is, in contrast to CyA, devoid of immunosuppressive efficacy while retaining full binding capacity to cyclophilin, and shows potent anti-H IV-1 activity in vitro. Thus [Melle 4]Cy selectively inhibits HIV-1 (strain IIIB) replication in the T4 lymphocyte cell line MT4, as measured by virus-induced cytopathic effects (Fig. 5 ), by viral p24 antigen production ( Fig. 6 ) and by infectious virus particle production (data not shown). HIV-1-induced cytopathic' effects are inhibited by [Melle 4]Cy, with a mean IC so value of 0.084 J..lg mr:', which is approximately 50-fold lower than the concentration that is inhibitory to MT4 cell growth (Fig.  5 ). Fig.6 shows p24 concentrations in supernatants from HIV-1 (strain IIIB)-infected MT4 cells treated with various concentrations of [Melle 4]Cy, and harvested on day 3 post-infection. A clear dose-dependent inhibitory effect on p24 production as a parameter for virus replication is demonstrated. From curves such as those shown in Fig. 6 the concentrations of the test compound that reduced p24 production by 50 and 90% were calculated. [Melle 4]Cy inhibited p24 production with a mean IC so value of 0.057 J..lg mr' and a mean ICgo value of 0.22 J..lg rnr' .
Antiviral activity could also be demonstrated in other cell lines, in primary T4 lymphocytes and monocytes, and against a selection of clinical isolates of HIV-1 from different geographic locations (Rosenwirth et al., in press ).
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Discussion
In this communication we report on the novel cyclosporin analogue [Melle 4]cyclosporin, which exhibits a high anti-HIV activity in vitro.
The structure of this new cyclosporin was confirmed using N-permethylation, hydrolytic cleavage, preparation of the isocyclosporin derivative and one-and two-dimensional NMR techniques.
Interestingly, fermentation yields higher amounts of [Melle 4]cyclosporin when D-threonine is added to the culture medium. The casein-peptone hydrolysate used as an amino acid and nitrogen source contains roughly equal amounts of free L-isoleucine and L-va.line (0.6%) but a five-fold excess of L-Ieucine, whereas L-threonine occurs in lower quantities (0.3%). The role of D-threonine supplementation of the nutrient medium in inducing the formation of [Melle 4]cyclosporin remains obscure. It is feasible that D-threonine is epimerized to L-allo-threonine by the non-specific alanine racemase present in Tolypocladium niveum (Offenzeller et et., 1993) . L-aThr itself, in contrast to L-Thr (Kobel and Traber, 1982) , does not serve as a favoured substrate for incorporation in cyclosporins at position 2 (Lawen and Traber, 1993) . Therefore, after being transformed by L-threonine dehydratase, which has been described as being non-specific with regard to the stereochemistry of the B-position (Davies, 1979) , L-aThr may enter the biosynthetic pathway to isoleucine. The rapid racemization of D-Thr would overcome, in this model, the known strong inhibition of L-threonine dehydratase by D-Thr (Hofler and Burns, 1978; Faleev et et., 1982) . Alternatively, the presence or induction of a specific D-threonine dehydratase in the fungus T. niveum, as has been observed in the bacterium Serratia marcescens (Komatsubara et sl., 1977; Crout et ei., 1980) , is also con- Cyclosporin synthetase (100 pi) was incubated as described previously (Lawen and Traber, 1993) ceivable. In this model D-Thr would be directly converted to L-lle.
In vitro biosynthesis using purified cyclosporin synthetase showed that this enzyme has a high affinity at position 4 for the amino acid isoleucine, indicating that limited supply of isoleucine rather than an enzymatic preference for leucine is the reason for the normal low amount of [Melle 4jcyclosporin formation by the fungus, This high affinity for lie at position 4 appears to be a unique feature of cyclosporin synthetase, since we did not obtain similar results with the related peptolide SDZ 214-103 synthetase' (Lawen et el., 1991; Lawen and Traber, 1993) . To our knowledge, in vivo and in vitro formation of [Melle 4jCy is the first example of the biosynthesis of a cyclosporin that does not exhibit any immunosuppressive activity.
The importance of this novel cyclosporin lies in its inhibition of HIV replication. [Melle 4jcyclosporin shows a binding capacity to cyclophilin that is comparable to that of cyclosporin A, but it does not show any immunosuppressive activity. This can be easily understood by considering the dual-domain concept of immunosuppressants (Baumann, 1992) : whereas the cyclophilin-binding domain of [Melle 4jCy has remained unchanged in comparison to CyA, the effector domain (calcineurin-binding domain) has been modified. Thus [Melle 4jCy can bind to cyclophilin and inhibit its petidyl-prolyl-cis/trans-isomerase (PPlase) activity (Fischer et et., 1989) , but the [Melle 4jcyclosporin-cyclophilin complex can no longer bind to calcineurin (Rosenwirth et el., in press) . Effects that are only dependent on the inhibition of cyclophilin's PPlase are therefore unchanged, but effects that require the inhibition of calcineurin (such as immunosuppression) are abo1-ished. This indicates that for anti-HIV activity binding to, and inhibition of, cyclophilin are crucial. With respect to immunosuppressivity, [Melle 4jcyclosporin is a powerful antagonist of CyA and therefore a putative tool for the elucidation of cellular signals that are affected by CyA. It seems to us that it is an advantage rather than a disadvantage for an anti-HIV drug not to exert immunosuppressive activity.
Materials and Experimental procedures
Strains and cultivation
The fungal strain used for fermentation (Cy E 4556) is a mutant from the parent strain NRRL 8044 of the species Tolypocladium niveum Gams. Culture conditions and media were as describedpreviously ."
Fifty Iitres of production medium inoculated with 5 I of the intermediate culture were supplemented with 4 g 1-1 of D-threonine, sterilized by filtration, and then transferred in 100-ml portions to fifty 500-ml Erlenmeyerflasks. After 14days of incubation at 27°C on a rotary shaker at 180 rpm, the fermentation broths were harvested.
For enzyme isolation, strain 7939/45 was used under the conditions describedpreviously (Lawen et el., 1989) .
Isolation and purification of {Melle 4]Cy
The mycelium was separated from the culture medium and extracted in a Turrax apparatus (Kinematica, Luzern, Switzerland) by stirring three times with 10 I of methanol/water (9:1 by volume). The crushed mycelium was separated by suction filtration, and the combined filtrates were concentrated under reduced pressure to remove the methanol. The aqueous solution was extractedfour times with 1,2-dichloroethane (21 each). The combinedorganic layers were evaporated to dryness.The crude residue was subjected to repeated silica gel chromatography using ethyl acetate saturated with water and chloroform/methanol (98:2 by volume), respectively, as eluents to give pure [Melle 4]Cy as a white amorphous powder.
Analytical methods
Thin layer chromatography (TLC) was performed on silica gel 60 F 254 plates (Merck, Darmstadt, Germany) using system I (ethyl acetate saturated with water) or system II [chloroform/methanol (96:4, by volume)), or on HPTLC silica gel 60 plates (Merck) using system I. The running span was 2 x 10 cm for system I and 10 cm for system II.
HPLC was performed on a Shandon Hypersil column (5 urn, 250 x 4.6 mm) at 75°C; mobile phase: acetonitrile/water/orthophosphoric acid (630:370:0.1 by volume); flow rate 1.2 ml min.; detection: UV absorption at 210 nm. The a-factor is defined as the relative retention time [(tR-to)/(tCyA -t o ]x10, where t R and t CyA are the corresponding retention times and to is the dead volume retention time. The CyA value was taken as reference (a = 10.00).
Chromatographical procedures ),,;1
Unless otherwise stated, silica gel (0.04-0,063 mm, Merck) was used for column chromatography.
Instrumental analysis
UV and IR spectra were measured on a Beckman (Fullerton, USA) DK2 spectrophotometer and a Perkin-Elmer (Norwalk, USA) spectrophotometer model 21, respectively. 1H NMR spectra were recorded on a Bruker (Karlsruhe, Germany) AM-360 instrument. FAB mass spectra were obtained using a Finnigan (Bremen, Germany) MAT 212 mass spectrometer at 8 keV using thioglycerine as the liquid matrix.
Amino acid analysis
Analytical scale: 1 (1 mg) was hydrolysed with 6N hydrochloric acid at 115°C for 24 h. The amino acids in the hydrolysate were analysed as N-pentafluoropropionyl-Q-isopropyl esters on a Varian-2800 gas chromatograph (Palo Alto, USA). Stationary phase: Chlrasll-Val'" 25 m x 0.25 mm (Macherey-Nagel, DOren, Germany); mobile phase: helium gas; flame ionization detector at 300°C.
Preparative isolation of amino acids: 1 (1.2 g; 1mmol) was refluxed in 35 ml 6N HCI for 18 h at 115°C. The hydrolysate was evaporated to dryness, and the residue taken up in water and passed through a weak anion-exchange column [Dowex-3 (The Dow Chemicals Co., USA), acetate form]. The mixture of free amino acids was then separated by column chromatography on cellulose (Avicel PH 101, FMC-Corporation, New Ark, USA) using 2-butanol saturated to 95% with water as eluent. The following amino acids were eluted and identified by comparison with reference samples: MeBmt-artifact (crystallized from methanol), m.p. 228-230°C, [a]o20 -25.2°(c 0.84 H 20) (ROegger et el., 1976) ; N-methyl-L-Ieucine (crystallized from acetone/water), [a]o20 +20.0° (c 1.30 H 20) ; N-methyl-L-valine (crystallized from methanol), [a]o20 +12.3°(c 0.83 H 20); L-valine (crystallized from acetone/water), [a]o20 +3.4°(c 1.43 H 20); L-a-aminobutyric acid (crystallized from 2-propanol/water), [a]o20 +18.1°(c 0.96 2N HCI); D,L-alanine (crystallized from methanol) [a]o20 0°(c 1.0 H 20) racemate; sarcosine (crystallized from methanol).
The mother-liquor of the MeLeu crystallization (277 mg) was further separated on silica gel using 1-propanol/water (8:2) 
Preparation of iso-[Melle 4jCy
(2) from [Melle 4jCy (1) 1 (720 mg; 0.6 mmol) and 144 mg (1.5 mmol) methanesulphonic acid were heated in 8.4ml dioxane for 24h at 50°C. After cooling to room temperature, sodium acetate (160 mg) was added to neutralize the acid. Insoluble material was filtered off, the filtrate was evaporated and the residue was taken up in CHCI 3 . After washing with water, the organic phase was evaporated and the crude product was chromatographed on silica gel using acetone/hexane (1:1 A preparation of hydrochloride: ethanolic HCI solution was added dropwise to 50 mg of 2 in 1 ml of methanol until acidic.
Evaporation to dryness gave the hydrochloride as a white amorphous powder.
Enzyme preparations and in vitro formation of [Melle 4jCy
Cyclosporin synthetase was isolated as previously reported (Lawen & Zocher, 1990) . For the biosynthesis of radiolabelled [Melle 4]Cy, 1 III of 0.1 M lie was added to a CyA biosynthesis incubation mixture (total volume: 121 Ill) as described (Lawen & Traber, 1993) .
Biological assays
The immunosuppressive activity, such as the inhibition of the proliferation of lymphocytes (mixed lymphocyte reaction) and the inhibition of the proliferation of tumor cells (Schreier et el., 1992) was determined in various in vitro assays. The cyclophilin binding assay was as described by Quesniaux et al. (1987) . The measurement of anti-HIV activity in vitro was carried out as follows.
(i) Inhibition of HIV-1-induced cytopathic effect in MT4 cells.
The assay procedure described by Pauwels et al. (1988) was used, with minor modifications. Briefly, the HTLV-1-transformed T4 cell line MT4, which was previously shown to be highly permissive for HIV infection, was used as the target cell. Inhibition of the HIV-1 (strain IIIB)-induced cytopathic effect was determined by measuring the viability of both HIV-and mock-infected cells. Viability was assessed spectrophotometrically via in situ reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT). Virus-infected and uninfected cultures without addition of the test compound were included as controls, as were uninfected cells treated with test compound. The cell concentration was chosen so that the number of cells per ml increased by a factor of·10 during the 5 days of incubation in mock-infected cultures. The virus inoculum was adjusted to cause cell death in 90% of the target cells after 5 days of incubation. The virus was adsorbed on to a cell suspension containing 10 6 cells mr' at 37 DC for 1 h. The infected cells were then diluted (1:10) and added to microtitre plates containing the test compound. Thus test compoundswere added post-adsorption.
(ii) Inhibition of HIV-1 (strain IIIB) replication in MT4 cells. MT4 cells were infected with HIV-1 (strain IIIB) by suspending the cells, at a concentration of 10 6 cells rnr', in virus solution.
Adsorption was allowed for 2 h at 37 DC. The virus inoculum was adjusted to give a linear increase of p24 antigen concentration in the supernatants of infected cells up to day 4 postinfection. After adsorption, the cells were spun down, the inoculum was removed by washing, and the infected cells were added to 6-well plates, containing the test compound at the appropiate concentration, to give 10 5 cells mr' in a volume of 5 ml. At days 3 and 4 post-infection, aliquots were removed, the cells were spun down and the supernatants were analysed for p24 antigen concentration by means of a commercial ELISA kit (Coulter Corp., Hialeah, USA).
